GTR 100823037
Bids Are Invited For Price Registration For Future Acquisition Of Agreed Injecting Drugs, In Meeting The Demand For Municipal Pharmaceutical Care, Within The Municipal Health Network Of The City Of Nova Alvorada Do Sul/Ms Valid For 12 Months.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
100823037
Tendering Authority
Subscribe to view
Tender No
024/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For Future Acquisition Of Agreed Injecting Drugs, In Meeting The Demand For Municipal Pharmaceutical Care, Within The Municipal Health Network Of The City Of Nova Alvorada Do Sul/Ms Valid For 12 Months.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
04-09-2025
Closed
Work Detail
Ascorbic Acid, Dosage: 100 Mg/Ml, Use: Injectable 10Ml, Tranexamic Acid, Dosage: 50 Mg/Ml, Pharmaceutical Form: 5Ml Injectable Solution, Adenosine, Dosage: 3 Mg/Ml, Indication: Injectable Solution, Sulfate, Dosage: 250 Mg/Ml, Aminophylli, Dosage: 24 Mg/Ml, Pharmaceutical Form: 10Ml Solution, 08/20/2025, Ampicillin 1G - Ampoule, Ampicillin, Concentration: 500 Mg, Pharmaceutical Form: Powder For Injectable Solution, Attractive Behesylate, Dosage: 10 Mg/Ml, Indication: Injectable Solution 2, 5Ml, Betamethasone, Composition: Dipopionate, Associated With Betamethasone Phosphate, Dosage: 5Mg + 2Mg, Injectable 1Ml, Biperidene, Composition: Hydrochloride, Concentration: 5 Mg/Ml, Pharmaceutical Form: 1Ml Injectable Solution, Sodium Bicarbonate, Dosage: 8, 4%, Use: Injectable 10Ml Solution, Use: 250Ml Bag, Bupivacahching, Hydrochloride Bag Purity: 0, 5%, Presentation: Injectable 20Ml Solution, Presentation: Associated With Glucose, Dosage: 0, 5% + 8%, Type: 4Ml Injectable Solution, Bromopride, Dosage: 5 Mg/Ml, Presentation: Injectable2ml, Sodium Cefazoline - Amp, Sodium Ceptriaxone, Concentration: 1 G, Ketoprofen 50 Mg/Ml. Cimetidine, Concentration: 150 Mg/Ml, Pharmaceutical Form: Injectable Solution 2Ml, Ciprofloxacin Hydrochloride, Dosage: 2 Mg/Ml, Presentation: 100Ml Injectable Solution, 200Ml Bag, Clindamycin, Dosage: 150 Mg/Ml, Presentation: 4Ml Injectable Solution, Chronidine Hydrochloride, Concentration: 0, 15 Mg/Ml, Pharmaceutical Form: Injectable Solution, Deslanoside, 2 Mg/Ml, Presentation: Injectable Solution 2Ml, Dexamethasone, Concentration: 2 Mg/Ml, Dextrocetamine Hydrochloride, Concentration: 50 Mg/Ml, Pharmaceutical Form: Injectable Solution, Diclofenac, Presentation: Sodium, Dosage: 25Mg/Ml, Use Injectable 3Ml, Dimenhydrinate, Presentation: Associated With Pyridoxine + Glucose + Fructose, Dosage: 3Mg + 5Mg + 100Mg/Ml, Medical Type: 10Ml Injectable Solution, Enoxaparin, Concentration: 100 Mg/Ml, Additional Characteristics 1: Completed Syringe 0, 20Ml, Subcutaneous, 40Ml, 60Ml, Scopolam Butylbromide, Presentation: Associated With Sodium Dipyrone, Dosage: 4Mg + 500Mg/Ml, Indication: 5Ml Injectable Solution, Dosage: 20 Mg/Ml, Indication: 1Ml Injectable Solution, Ethylephrine Hydrochloride, Composition: 10Mg/Ml, Presentation: 1Ml Injectable, Sulfate Presentation: 50Mg/Ml, Solution Injectable, Ethomidate 2Mg/Ml Ampoule, Estradiol, Presentation: Valerato Associated With Noretisterone Enanthato, Dosage: 5Mg + 50Mg/1Ml, Use: Injectable 1Ml, Fentanyl, Presentation: Salt, 05 Mg/Ml, Indication: 10Ml Injectable Solution, Indication: 2 Ml Injectable Solution, Sodium Phosphate, Presentation: Enema, Dosage: 16% + Dibasic Phosphate 6%,%, Flask 130Ml, Phytomenadione 10Mg/Ml, Presentation: Injectable Solution, Fluconazole 2Mg/Ml Fr 100Ml Iv, Gentamycin, Dosage: 80 Mg, Application: 2Ml Solution, Glycerol, Dosage: 95%, 95% Presentation: Childrens Suppository, 10% Amp Calcium Glycone, Haloperidol, Presentation: Decanoate Salt, Use Type: Injectable 1Ml Solution, Sodium Heparin, 5,000Ui/Ml, Indication: Injectable (5Ml), Iron Hydroxide Iii, Concentration: 20 Mg/Ml, Pharmaceutical Form: 5Ml Injectable Solution, Human Immunoglobulin, Type: Anti Rho (D), Dosage: 300 Mcg, Levofloxacin, Medroxyprogesterone Acetate, Metilergometrine 0, 2Mg/Ml Inj, 1 Ml, Methylprednisolone Succc 125Mg Fa+ Dil 2Ml, Methylprednisolone, Active Ingredient: Succinato, Dosage: 500 Mg, Presentation: Powder Lyophilized + Diluent, Injectable, Metoprolol, Concentration: 1 Mg/Ml, Metronidazole, Dosage: 5Mg/Ml
Key Value
Tender Value
916,524 - BRL
Tender Documents
Global Tender Document
19349773-3d8b-4255-9e80-d1be64b71810.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.